{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:42:32Z","timestamp":1789051352689,"version":"build-2803163510"},"reference-count":24,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304628"],"award-info":[{"award-number":["82304628"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ23H160047"],"award-info":[{"award-number":["LQ23H160047"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with an extremely poor prognosis, and current clinical treatment options are limited. Natural products, due to their multi-target and low-toxicity characteristics, have emerged as an important direction for the development of anti-tumor drugs. Palmaturbine (Pal), an isoquinoline alkaloid derived from Coptis chinensis and Berberis species, has shown anti-inflammatory and anti-tumor potential in preliminary studies; however, its mechanism of action in PDAC remains unclear. This study systematically evaluated the anti-tumor effects and molecular mechanisms of Pal on PDAC through in vitro and in vivo experiments. In vitro, Pal significantly inhibited PDAC cell proliferation, migration, and invasion, induced G2\/M phase cell cycle arrest, and promoted apoptosis. Transcriptomic sequencing and Western blot analysis revealed that Pal suppressed the JAK2\/STAT3 signaling pathway by inhibiting the phosphorylation of JAK2 and STAT3. Animal experiments further indicated that Pal significantly inhibited the growth of subcutaneous xenograft tumors in nude mice without causing obvious toxicity. In summary, Pal, as a natural JAK\/STAT pathway inhibitor, exhibits favorable anti-tumor activity and safety in PDAC treatment, holding potential as a novel candidate drug for PDAC.<\/jats:p>","DOI":"10.3390\/ijms27041707","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:16:38Z","timestamp":1770722198000},"page":"1707","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Palmaturbine Inhibits Pancreatic Ductal Adenocarcinoma by Suppressing the JAK2\/STAT3 Signaling Pathway"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1275-2862","authenticated-orcid":false,"given":"Hong-Zhang","family":"Shen","sequence":"first","affiliation":[{"name":"School of Medicine, Zhejiang University, Hangzhou 310058, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yun","family":"Zheng","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Chao","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4090-0551","authenticated-orcid":false,"given":"Yu-Lian","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Medicine, Zhejiang University, Hangzhou 310058, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"ref_1","first-page":"10","article-title":"Cancer Statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"19609","DOI":"10.1073\/pnas.1908626116","article-title":"Proteomic Analyses of ECM during Pancreatic Ductal Adenocarcinoma Progression Reveal Different Contributions by Tumor and Stromal Cells","volume":"116","author":"Tian","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic Cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jamasurg.2020.2286","article-title":"Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma","volume":"155","author":"Perri","year":"2020","journal-title":"JAMA Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S2468-1253(20)30330-7","article-title":"Nab-Paclitaxel plus Gemcitabine versus Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX Induction Chemotherapy in Locally Advanced Pancreatic Cancer (NEOLAP-AIO-PAK-0113): A Multicentre, Randomised, Phase 2 Trial","volume":"6","author":"Kunzmann","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41467-025-67197-3","article-title":"Targeting TNK2\/ACK1 Reverses the Immunosuppressive Tumor Microenvironment and Synergizes with Immunochemotherapy in Pancreatic Cancer","volume":"17","author":"Wu","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"107577","DOI":"10.1016\/j.phrs.2025.107577","article-title":"Natural Products Targeting RAS by Multiple Mechanisms and Its Therapeutic Potential in Cancer: An Update since 2020","volume":"212","author":"Liu","year":"2025","journal-title":"Pharmacol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yeo, H., Kim, S.-Y., and Park, S.-M. (2025). Harnessing Transcriptomics for Discovery of Natural Products to Overcome Acquired Cancer Resistance. Arch. Pharm. Res.","DOI":"10.1007\/s12272-025-01590-w"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"He, X., Wang, N., Zhang, Y., Huang, X., and Wang, Y. (2022). The Therapeutic Potential of Natural Products for Treating Pancreatic Cancer. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1051952"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.21037\/jgo-22-802","article-title":"Curcumin Inhibits Pancreatic Cancer Cell Proliferation by Regulating Beclin1 Expression and Inhibiting the Hypoxia-Inducible Factor-1\u03b1-Mediated Glycolytic Pathway","volume":"13","author":"Guo","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00109-010-0669-3","article-title":"Celastrol Suppresses Invasion of Colon and Pancreatic Cancer Cells through the Downregulation of Expression of CXCR4 Chemokine Receptor","volume":"88","author":"Yadav","year":"2010","journal-title":"J Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"106126","DOI":"10.1016\/j.phrs.2022.106126","article-title":"Natural Isoquinoline Alkaloids: Pharmacological Features and Multi-Target Potential for Complex Diseases","volume":"177","author":"Plazas","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic Cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-11-0908","article-title":"STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis","volume":"71","author":"Corcoran","year":"2011","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1038\/onc.2013.257","article-title":"The Immune Network in Pancreatic Cancer Development and Progression","volume":"33","author":"Diakopoulos","year":"2014","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/s41467-024-47949-3","article-title":"Macrophage-Fibroblast JAK\/STAT Dependent Crosstalk Promotes Liver Metastatic Outgrowth in Pancreatic Cancer","volume":"15","author":"Raymant","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Carnazza, M., Yang, N., Tiwari, R.K., Geliebter, J., and Li, X.-M. (2025). Natural Compounds Targeting MAPK, PI3K\/Akt, and JAK\/STAT Signaling in Papillary Thyroid Cancer. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262110498"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kubatka, P., Huniadi, M., Kapinova, A., Nosalova, N., Varghese, E., Blahutova, D., Hornak, S., Trbolova, A., Biringer, K., and Adamicova, K. (2025). Flavonoid-Modulated JAK-STAT Signaling Mitigates Malignant Transformation and Drug Resistance in Breast Tumors: A Clinically Relevant 3PM-Guided Innovation. J. Adv. Res.","DOI":"10.1016\/j.jare.2025.10.067"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110505","DOI":"10.1016\/j.intimp.2023.110505","article-title":"The ALOX5 Inhibitor Zileuton Regulates Tumor-Associated Macrophage M2 Polarization by JAK\/STAT and Inhibits Pancreatic Cancer Invasion and Metastasis","volume":"121","author":"Hu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3892\/or.2017.5399","article-title":"The JAK\/STAT Pathway Is Involved in the Upregulation of PD-L1 Expression in Pancreatic Cancer Cell Lines","volume":"37","author":"Doi","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.3892\/or.2016.5093","article-title":"13-Methyl-Palmatrubine Induces Apoptosis and Cell Cycle Arrest in A549 Cells in Vitro and in Vivo","volume":"36","author":"Chen","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"108468","DOI":"10.1016\/j.intimp.2021.108468","article-title":"13-Methyl-Palmatrubine Shows an Anti-Tumor Role in Non-Small Cell Lung Cancer via Shifting M2 to M1 Polarization of Tumor Macrophages","volume":"104","author":"Wu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"115760","DOI":"10.1016\/j.addr.2025.115760","article-title":"Emerging Nanoparticle-Based Therapies for Pancreatic Cancer: Current Clinical Landscape","volume":"229","author":"Zalba","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/scbi.1995.0027","article-title":"The Role of Protein Phosphatase Type-2A in the Xenopus Cell Cycle: Initiation of the G2\/M Transition","volume":"6","author":"Lee","year":"1995","journal-title":"Semin. Cancer Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/4\/1707\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T09:19:33Z","timestamp":1770801573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/4\/1707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ijms27041707"],"URL":"https:\/\/doi.org\/10.3390\/ijms27041707","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}